WASHINGTON (Reuters) – The Biden administration is seeking to meet with the makers of the life-saving medication naloxone used to reverse opioid overdoses to discuss access and affordability, a spokesperson for the White House Office of National Drug Control Policy said.
(Reporting by Susan Heavey; editing by Paul Grant)
